PhysiomicsÂ’ vision is to transform oncology drug development. We believe in innovation, collaboration, diversity and inclusion and we aim to bring out the best in each other, in order to help our partners develop great cancer drugs and to apply them optimally in real-world settings.
| CEO: |
Peter Sargent |
| COO: |
Christophe Chassagnole |
| Non-Executive Chairman: |
James Simon Millen |
| Independent Non-Executive Director: |
Timothy (Tim) Corn, Shalabh Kumar |
| Address: |
Bee House, 140 Eastern Avenue, Milton Park, Oxfordshire, United Kingdom |
| Phone: |
+44 (0) 186 5784 980 |
| Fax: |
|
| Website: |
http://www.physiomics.co.uk/ |
| Email: |
|